Genetic Variant Detection And Health Risk Assessment System
PTA is the FDA product code for Genetic Variant Detection And Health Risk Assessment System, a class II device type, regulated under 21 CFR 866.5950. FDA's definition for this code reads: "A qualitative in vitro molecular test that detects variants in genomic DNA isolated from human specimens. This assessment system provides users with a genetic health risk assessment of developing a disease and is intended to inform users of lifestyle choices and/or encourage conversations with a healthcare...". As of , FDA records hold 5 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- PTA
- Device name
- Genetic Variant Detection And Health Risk Assessment System
- FDA definition
- A qualitative in vitro molecular test that detects variants in genomic DNA isolated from human specimens. This assessment system provides users with a genetic health risk assessment of developing a disease and is intended to inform users of lifestyle choices and/or encourage conversations with a healthcare professional. This assessment system is for over-the-counter use. This device does not determine the person’s overall risk of developing a disease.
- Regulation
- 21 CFR 866.5950
- Device class
- Class II
- Review panel
- Immunology
- Submission type
- 510(k) exempt
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 5
- Ingested recalls
- 0
Clearances, product code PTA
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2017 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2025 | 1 |
Applicants with the most clearances
Product code PTA| Applicant | Clearances |
|---|---|
| 23AndMe, Inc. | 1 |
| Ancestry Genomics, Inc. | 1 |
| Helix Opco, LLC | 1 |
| Progenika Biopharma S.A., A Grifols Company | 1 |
| Targeted Genomics, LLC | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
